Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

about

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas.

P2860

Q52571294-937BDEB1-C5D7-4CFB-816C-E790A77C64F8

P2860

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

Item

http://www.wikidata.org/entity/Q40057309

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

@en

type

Item

label

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

@en

prefLabel

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

@en

P1476

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

@en

P2093

Charlotte G Hannibal

http://www.w3.org/2001/XMLSchema#string

Deyin Xing

http://www.w3.org/2001/XMLSchema#string

Felix Zeppernick

http://www.w3.org/2001/XMLSchema#string

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Russell Vang

http://www.w3.org/2001/XMLSchema#string

Susanne K Kjaer

http://www.w3.org/2001/XMLSchema#string

Tian-Li Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Origin and molecular pathogenesis of ovarian high-grade serous carcinoma

Type-specific cell line models for type-specific ovarian cancer research

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.

Molecular genetic analysis of ovarian serous cystadenomas.

BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors

P304

87-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HUMPATH.2017.08.021

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yohan Suryo Rahmanto

P577

2017-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28873354

http://www.w3.org/2001/XMLSchema#string

P932

5696063

http://www.w3.org/2001/XMLSchema#string

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

about

P2860

P2860

Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932